1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Analysis & Statistics in Spain, May 2020

Cancer Analysis & Statistics in Spain, May 2020

1-30 of about 200 reports

2020 Spain Tumor Marker Testing Market: Supplier Shares, Volume and Sales Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers

  • $ 2450
  • May 2020
  • 565 pages

2020 Spain Tumor Marker Testing Market: Supplier Shares, Volume and Sales Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers H ...

  • Cancer
  • Spain
  • Demand

Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC)— Epidemiology Forecast to 2030

  • $ 2850
  • May 2020
  • 100 pages

‘Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC)— Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted EGFR-NSCLC ...

  • Cancer
  • Lung Cancer
  • Pathology
  • Spain
  • United States

Programmed death-ligand 1 (PD-L1) Non-small Cell Lung Cancer (NSCLC) - Epidemiology Forecast to 2030

  • $ 2850
  • May 2020
  • 100 pages

‘Programmed death-ligand 1 (PD-L1) Non-small Cell Lung Cancer (NSCLC) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted PD-L1 NSCLC ...

  • Cancer
  • Lung Cancer
  • Pathology
  • Spain
  • United States

Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC)- Epidemiology Forecast to 2030

  • $ 2850
  • May 2020
  • 100 pages

‘Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC)- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical ...

  • Cancer
  • Lung Cancer
  • Pathology
  • Spain
  • United Kingdom

BRAF Mutated Non-small Cell Lung Cancer (NSCLC) - Epidemiology Forecast to 2030

  • $ 2850
  • May 2020
  • 100 pages

‘BRAF Mutated Non-small Cell Lung Cancer (NSCLC)- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted BRAF Mutated NSCLC epidemiology ...

  • Cancer
  • Lung Cancer
  • Pathology
  • Spain
  • United Kingdom

Anaplastic lymphoma kinase Non Small Cell Lung Cancer (ALK-NSCLC) - Epidemiology Forecast to 2030

  • $ 2850
  • May 2020
  • 100 pages

‘Anaplastic lymphoma kinase-Non Small Cell Lung Cancer (ALK-NSCLC)- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted ALK NSCLCepidemiology ...

  • Cancer
  • Lung Cancer
  • Pathology
  • Germany
  • Spain

2020 Spain Hospital Tumor Marker Testing Market: Supplier Shares by Test and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentstion Review, Emerging Opportunities

  • $ 2500
  • April 2020
  • 521 pages

2020 Spain Hospital Tumor Marker Testing Market: Supplier Shares by Test and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentstion Review, Emerging Opportunities This new report ...

  • Cancer
  • Pathology
  • Spain
  • Demand

2020 Spain Hospital Cancer Diagnostics Market Forecasts for Major Tumor Markers: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review

  • $ 2500
  • April 2020
  • 521 pages

2020 Spain Hospital Cancer Diagnostics Market Forecasts for Major Tumor Markers: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review This new report from  ...

  • Cancer
  • Pathology
  • Spain
  • Forecast

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) - Epidemiology Forecast - 2030

  • $ 3750
  • April 2020
  • 72 pages

‘Blastic plasmacytoid dendritic cell neoplasm (BPDCN) – Epidemiology Forecast—2030’ report delivers an in-depth understanding of the BPDCN, historical and forecasted epidemiology in the United ...

  • Biopharmaceutical
  • Cancer
  • Cell Therapy
  • Medical Biotechnology
  • Spain

2020 Spain Tumor Marker Testing Analyzers and Reagents: Supplier Shares and Strategies, Volume and Sales Segment Forecasts by Product--Competitive Profiles, Technology and Instrumentation Review, Opportunities for Suppliers

  • $ 3500
  • February 2020
  • 565 pages

2020 Spain Tumor Marker Testing Analyzers and Reagents: Supplier Shares and Strategies, Volume and Sales Segment Forecasts by Product--Competitive Profiles, Technology and Instrumentation Review, Opportunities ...

  • Cancer
  • Spain
  • Demand

Colorectal Cancer: Epidemiology Forecast to 2028

  • $ 3995
  • November 2019
  • 47 pages

Colorectal Cancer: Epidemiology Forecast to 2028 Summary Colorectal cancer (CRC) is a cancer that occurs in the large intestine or large bowel (Centers for Disease Control and Prevention, 2019).Most CRCs ...

  • Cancer
  • Colorectal Cancer
  • Japan
  • Spain
  • Forecast

Spain Hospital Tumor Marker Forecasts for Major Tests: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review

  • $ 2500
  • November 2019
  • 521 pages

Spain Hospital Tumor Marker Forecasts for Major Tests: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review This new report contains 521 pages, 41 tables, and ...

  • Cancer
  • Spain

Spain Hospital Cancer Diagnostics Market Forecasts for Major Tumor Markers: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review

  • $ 2500
  • November 2019
  • 521 pages

Spain Hospital Cancer Diagnostics Market Forecasts for Major Tumor Markers: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review This new report from  ...

  • Cancer
  • Spain
  • Forecast

Embolotherapy Market

  • $ 4900
  • September 2019
  • 336 pages

Embolotherapy Market Research Report: By Product (Embolic Agents, Support Devices), Procedure (Transcatheter Arterial Embolization, Transarterial Radioembolization/Selective Internal Radiation Therapy, ...

  • Cancer
  • Pathology
  • Spain
  • United Kingdom
  • Demand

Ovarian Cancer: Epidemiology Forecast to 2028

  • $ 3995
  • July 2019
  • 46 pages

Ovarian Cancer: Epidemiology Forecast to 2028 Summary Ovarian cancer is the most lethal gynecologic cancer and overall a leading cause of cancer incidence and mortality worldwide. The disease is defined ...

  • Cancer
  • Ovarian Cancer
  • Japan
  • Spain
  • Forecast

Spain Tumor Marker Testing Analyzers and Reagents Market, 2019-2023: Supplier Shares and Sales Segment Forecasts by Product--Competitive Intelligence, Technology and Instrumentation Review, Opportunities for Suppliers

  • $ 4350
  • July 2019
  • 565 pages

Spain Tumor Marker Testing Analyzers and Reagents Market, 2019-2023: Supplier Shares and Sales Segment Forecasts by Product--Competitive Intelligence, Technology and Instrumentation Review, Opportunities ...

  • Cancer
  • Spain
  • Demand

Spain Tumor Marker Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers, 2019-2023

  • $ 2450
  • July 2019
  • 565 pages

Spain Tumor Marker Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers, 2019-2023 HighlightsComprehensive ...

  • Cancer
  • Spain
  • Market Shares

Spain Hospital Tumor Marker Testing Market, 2019-2023: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities

  • $ 2500
  • May 2019
  • 521 pages

Spain Hospital Tumor Marker Testing Market, 2019-2023: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities This new report from V ...

  • Cancer
  • Pathology
  • Spain
  • Demand

Spain Hospital Tumor Marker Testing Market, 2019-2023: Supplier Shares, Competitive Landscape, Innovative Technologies, Instrumentation Review

  • $ 2500
  • May 2019
  • 521 pages

Spain Hospital Tumor Marker Testing Market, 2019-2023: Supplier Shares, Competitive Landscape, Innovative Technologies, Instrumentation Review This new report contains 521 pages, 41 tables, and presents ...

  • Cancer
  • Pathology
  • Spain
  • Demand

Spain Hospital Cancer Diagnostics Market, 2019-2023: Supplier Shares, Competitive Landscape, Innovative Technologies, Instrumentation Review

  • $ 2500
  • May 2019
  • 521 pages

Spain Hospital Cancer Diagnostics Market, 2019-2023: Supplier Shares, Competitive Landscape, Innovative Technologies, Instrumentation Review This new report from  LeadingMarketResearch.com contains ...

  • Cancer
  • Pathology
  • Spain
  • Demand

2019 Spain Tumor Marker Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers

  • $ 2450
  • April 2019
  • 565 pages

2019 Spain Tumor Marker Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers HighlightsComprehensive 565-page ...

  • Cancer
  • Spain
  • Market Shares

2019-2023 Spain Tumor Marker Testing Analyzers and Reagents Market: Supplier Shares and Sales Segment Forecasts by Product--Competitive Intelligence, Technology and Instrumentation Review, Opportunities for Suppliers

  • $ 6800
  • March 2019
  • 565 pages

2019-2023 Spain Tumor Marker Testing Analyzers and Reagents Market: Supplier Shares and Sales Segment Forecasts by Product--Competitive Intelligence, Technology and Instrumentation Review, Opportunities ...

  • Cancer
  • Pathology
  • Spain
  • Demand

Bioprognos SL - Product Pipeline Analysis, 2018 Update

  • $ 750
  • December 2018
  • 22 pages

Summary Bioprognos SL (Bioprognos) is a cancer diagnostics company that develops non-invasive and accurate diagnostics solutions.The company’s pipeline products include OncoBREAST Dx, OncoLUNG Dx, OncoOVARIAN ...

  • Cancer
  • Spain
  • United States
  • Company
  • Product Initiative

Pharma Mar SA (PHM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • November 2018
  • 55 pages

Summary Pharma Mar SA (Pharma Mar) is a biopharmaceutical company that discovers, develops and markets marine-derived drugs to treat cancer.The company’s marketed product Yondelis (trabectedin), a novel, ...

  • Cancer
  • Medical Biotechnology
  • Spain
  • Company
  • Pharma Mar, S.A.

Spanish National Cancer Research Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • November 2018
  • 28 pages

Summary Spanish National Cancer Research Center (CNIO) is a medical research center that conducts cancer research programs.The center integrates basic and translational cancer research. It conducts various ...

  • Cancer
  • Pharmaceutical
  • Specialty Hospital
  • Therapy
  • Spain

Bellvitge Biomedical Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • November 2018
  • 49 pages

Summary Bellvitge Biomedical Research Institute (IDIBELL) is a biomedical research center that offers health care development solutions.The center conducts clinical and basic research for developing treatments ...

  • Cancer
  • Healthcare
  • Pharmaceutical
  • Therapy
  • Spain

Myc Proto Oncogene Protein (Transcription Factor p64 or Class E Basic Helix Loop Helix Protein 39 or MYC) - Pip Review, H2 2018

  • $ 3500
  • September 2018
  • 39 pages

Myc Proto Oncogene Protein (Transcription Factor p64 or Class E Basic Helix Loop Helix Protein 39 or MYC) - Pip Review, H2 2018 Summary Myc Proto Oncogene Protein (Transcription Factor p64 or Class E ...

  • Cancer
  • Therapy
  • Spain
  • Product Initiative
  • Phylogica Limited

Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU

  • $ 7995
  • September 2018
  • 162 pages

Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU Summary Market access of oncology medicines is increasingly challenging due to the rising cost of new and innovative medicines, ...

  • Cancer
  • Spain
  • Bristol-Myers Squibb Company
  • Novartis AG
  • PROVENGE group

Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta (Nuclear Factor NF Kappa B Inhibitor Kinase Beta or I Kappa B Kinase 2 or IKBKB or EC 2.7.11.10) - Pipeline Review, H2 2018

  • $ 3500
  • August 2018
  • 38 pages

Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta (Nuclear Factor NF Kappa B Inhibitor Kinase Beta or I Kappa B Kinase 2 or IKBKB or EC 2.7.11.10) - Pipeline Review, H2 2018 Summary Inhibitor of ...

  • Cancer
  • Targeted Therapy
  • Spain
  • Product Initiative
  • IMMD

Immunovia AB (IMMNOV) - Product Pipeline Analysis, 2018 Update

  • $ 750
  • July 2018
  • 32 pages

Summary Immunovia AB (Immunovia) is a molecular diagnostics company that offers clinical testing for early diagnosis of pancreatic cancer.The company develops IMMray, a technology platform based on antibody ...

  • Cancer
  • Hospital
  • Pancreatic Cancer
  • Spain
  • Product Initiative
About 200 reports

Download Unlimited Documents from Trusted Public Sources

View report >

Global Colorectal Cancer Statistics

  • January 2020
  • 20 pages
  • Cancer
  • Colorectal Cancer
  • Pathology
  • Spain
  • Baishideng Publishing Group Inc

Nutrition Industry February 2019

Cancer Statistics January 2019


Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on